July 31, 2026| Regulatory news and announcements, Regulatory news and notifications| Tenzin Wangmo
The Bhutan Food and Drug Authority (BFDA) has issued the attached Regulatory Notification and Public Safety... Read More → BFDA Regulatory Notification and Public Safety Advisory On Unregistered Medicinal Product Containing Undeclared Diclofenac.
July 10, 2026| Regulatory news and announcements| Tenzin Wangmo
This is to inform you that we will conduct the Competency Examination on 07 September 2026 from 09:30 AM at... Read More → Competency Exam on 07 September 2026
May 22, 2026| Regulatory news and announcements| Tenzin Wangmo
The Medical product division under Bhutan food and Drug Authority is pleased to share the final draft... Read More → Public Consultation for Guideline on Importation, Consignment Verification and Lot release of Medical Product 2026.
May 8, 2026| Regulatory news and announcements| Tenzin Wangmo
... Read More → Competency Examination on 06 July
May 4, 2026| Regulatory news and announcements| Tenzin Wangmo
The BFDA is sharing the guideline for your comments. This will be consulted for a period of two months from... Read More → Public Consultation on revised Guideline for Registration of Medical Devices.
May 1, 2026| Regulatory news and notifications| Tenzin Wangmo
The Medical Product Division of the Bhutan Food and Drug Authority (BFDA) is pleased to share the draft... Read More → Public Consultation on Draft Guideline for Good Storage and distribution Practices.
March 23, 2026| Regulatory news and announcements| Tenzin Wangmo
This is to inform you that we will conduct the Competency Examination on 05 May, 2026 from 09:30 AM at the... Read More → Competency Examination on 05 May, 2026
March 17, 2026| Regulatory news and notifications| Tenzin Wangmo
... Read More → Notification-Revised Market Authorization Guidelines.
March 16, 2026| Regulatory news and notifications| Tenzin Wangmo
... Read More → Regulatory Notification on Publication of Irrational FDC
... Read More → Regulatory Notification on publication of Bioequivalence and Biowaiver list
July 31, 2026
July 10, 2026
July 3, 2026
Accessibility Tools
